Colorectal cancer screening: Clinical practice guidelines in oncology™

Randall W. Burt, James S. Barthel, Kelli Bullard Dunn, Donald S. David, Ernesto Drelichman, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley R. Hamilton, Mohammad K. Ismail, Kory Jasperson, Audrey J. Lazenby, Patrick M. Lynch, Edward W. Martin, Robert J. Mayer, Reid M. Ness, Dawn Provenzale, M. Sambasiva Rao, Moshe ShikeGideon Steinbach, Jonathan P. Terdiman, David Weinberg

Research output: Contribution to journalReview article

118 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and women in the United States. Patients with localized colon cancer have a 90% 5-year survival rate, and CRC mortality can be reduced through early diagnosis and cancer prevention with polypectomy. Therefore, the goal of CRC screening is to detect cancer at an early, curable stage and to detect and remove clinically significant adenomas. Screening tests that can detect both early cancer and adenomatous polyps are encouraged, although the panel recognizes that patient preference and resource accessibility play a large role in test selection. Current technology falls into 2 broad categories: structural and stool! fecal-based tests. Although some techniques are better established than others, the guidelines panelists agree that any screening is better than none. Important updates for 2010 include the addition of surveillance guidelines and definitions for several polyposis syndromes, including Peutz-Jeghers syndrome and juvenile polyposis syndrome, and modifications to screening modality and schedule recommendations.

Original languageEnglish (US)
Pages (from-to)8-60
Number of pages53
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number1
StatePublished - Jan 2010

Fingerprint

Early Detection of Cancer
Practice Guidelines
Colorectal Neoplasms
Guidelines
Peutz-Jeghers Syndrome
Adenomatous Polyps
Neoplasms
Patient Preference
Adenoma
Colonic Neoplasms
Appointments and Schedules
Survival Rate
Technology
Mortality

Keywords

  • APC
  • Adenoma
  • Colon cancer screening
  • Colon polyp
  • Colonoscopy
  • Colorectal cancer
  • FAP
  • FIT test
  • Fecal occult blood test
  • HNPCC
  • Lynch syndrome
  • NCCN clinical practice guidelines
  • Stool DNA

ASJC Scopus subject areas

  • Oncology

Cite this

Burt, R. W., Barthel, J. S., Dunn, K. B., David, D. S., Drelichman, E., Ford, J. M., ... Weinberg, D. (2010). Colorectal cancer screening: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 8(1), 8-60.

Colorectal cancer screening : Clinical practice guidelines in oncology™. / Burt, Randall W.; Barthel, James S.; Dunn, Kelli Bullard; David, Donald S.; Drelichman, Ernesto; Ford, James M.; Giardiello, Francis M.; Gruber, Stephen B.; Halverson, Amy L.; Hamilton, Stanley R.; Ismail, Mohammad K.; Jasperson, Kory; Lazenby, Audrey J.; Lynch, Patrick M.; Martin, Edward W.; Mayer, Robert J.; Ness, Reid M.; Provenzale, Dawn; Rao, M. Sambasiva; Shike, Moshe; Steinbach, Gideon; Terdiman, Jonathan P.; Weinberg, David.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 1, 01.2010, p. 8-60.

Research output: Contribution to journalReview article

Burt, RW, Barthel, JS, Dunn, KB, David, DS, Drelichman, E, Ford, JM, Giardiello, FM, Gruber, SB, Halverson, AL, Hamilton, SR, Ismail, MK, Jasperson, K, Lazenby, AJ, Lynch, PM, Martin, EW, Mayer, RJ, Ness, RM, Provenzale, D, Rao, MS, Shike, M, Steinbach, G, Terdiman, JP & Weinberg, D 2010, 'Colorectal cancer screening: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 1, pp. 8-60.
Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM et al. Colorectal cancer screening: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2010 Jan;8(1):8-60.
Burt, Randall W. ; Barthel, James S. ; Dunn, Kelli Bullard ; David, Donald S. ; Drelichman, Ernesto ; Ford, James M. ; Giardiello, Francis M. ; Gruber, Stephen B. ; Halverson, Amy L. ; Hamilton, Stanley R. ; Ismail, Mohammad K. ; Jasperson, Kory ; Lazenby, Audrey J. ; Lynch, Patrick M. ; Martin, Edward W. ; Mayer, Robert J. ; Ness, Reid M. ; Provenzale, Dawn ; Rao, M. Sambasiva ; Shike, Moshe ; Steinbach, Gideon ; Terdiman, Jonathan P. ; Weinberg, David. / Colorectal cancer screening : Clinical practice guidelines in oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2010 ; Vol. 8, No. 1. pp. 8-60.
@article{d158f783af4e4da6b2fc50efab485810,
title = "Colorectal cancer screening: Clinical practice guidelines in oncology™",
abstract = "Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and women in the United States. Patients with localized colon cancer have a 90{\%} 5-year survival rate, and CRC mortality can be reduced through early diagnosis and cancer prevention with polypectomy. Therefore, the goal of CRC screening is to detect cancer at an early, curable stage and to detect and remove clinically significant adenomas. Screening tests that can detect both early cancer and adenomatous polyps are encouraged, although the panel recognizes that patient preference and resource accessibility play a large role in test selection. Current technology falls into 2 broad categories: structural and stool! fecal-based tests. Although some techniques are better established than others, the guidelines panelists agree that any screening is better than none. Important updates for 2010 include the addition of surveillance guidelines and definitions for several polyposis syndromes, including Peutz-Jeghers syndrome and juvenile polyposis syndrome, and modifications to screening modality and schedule recommendations.",
keywords = "APC, Adenoma, Colon cancer screening, Colon polyp, Colonoscopy, Colorectal cancer, FAP, FIT test, Fecal occult blood test, HNPCC, Lynch syndrome, NCCN clinical practice guidelines, Stool DNA",
author = "Burt, {Randall W.} and Barthel, {James S.} and Dunn, {Kelli Bullard} and David, {Donald S.} and Ernesto Drelichman and Ford, {James M.} and Giardiello, {Francis M.} and Gruber, {Stephen B.} and Halverson, {Amy L.} and Hamilton, {Stanley R.} and Ismail, {Mohammad K.} and Kory Jasperson and Lazenby, {Audrey J.} and Lynch, {Patrick M.} and Martin, {Edward W.} and Mayer, {Robert J.} and Ness, {Reid M.} and Dawn Provenzale and Rao, {M. Sambasiva} and Moshe Shike and Gideon Steinbach and Terdiman, {Jonathan P.} and David Weinberg",
year = "2010",
month = "1",
language = "English (US)",
volume = "8",
pages = "8--60",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Colorectal cancer screening

T2 - Clinical practice guidelines in oncology™

AU - Burt, Randall W.

AU - Barthel, James S.

AU - Dunn, Kelli Bullard

AU - David, Donald S.

AU - Drelichman, Ernesto

AU - Ford, James M.

AU - Giardiello, Francis M.

AU - Gruber, Stephen B.

AU - Halverson, Amy L.

AU - Hamilton, Stanley R.

AU - Ismail, Mohammad K.

AU - Jasperson, Kory

AU - Lazenby, Audrey J.

AU - Lynch, Patrick M.

AU - Martin, Edward W.

AU - Mayer, Robert J.

AU - Ness, Reid M.

AU - Provenzale, Dawn

AU - Rao, M. Sambasiva

AU - Shike, Moshe

AU - Steinbach, Gideon

AU - Terdiman, Jonathan P.

AU - Weinberg, David

PY - 2010/1

Y1 - 2010/1

N2 - Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and women in the United States. Patients with localized colon cancer have a 90% 5-year survival rate, and CRC mortality can be reduced through early diagnosis and cancer prevention with polypectomy. Therefore, the goal of CRC screening is to detect cancer at an early, curable stage and to detect and remove clinically significant adenomas. Screening tests that can detect both early cancer and adenomatous polyps are encouraged, although the panel recognizes that patient preference and resource accessibility play a large role in test selection. Current technology falls into 2 broad categories: structural and stool! fecal-based tests. Although some techniques are better established than others, the guidelines panelists agree that any screening is better than none. Important updates for 2010 include the addition of surveillance guidelines and definitions for several polyposis syndromes, including Peutz-Jeghers syndrome and juvenile polyposis syndrome, and modifications to screening modality and schedule recommendations.

AB - Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and women in the United States. Patients with localized colon cancer have a 90% 5-year survival rate, and CRC mortality can be reduced through early diagnosis and cancer prevention with polypectomy. Therefore, the goal of CRC screening is to detect cancer at an early, curable stage and to detect and remove clinically significant adenomas. Screening tests that can detect both early cancer and adenomatous polyps are encouraged, although the panel recognizes that patient preference and resource accessibility play a large role in test selection. Current technology falls into 2 broad categories: structural and stool! fecal-based tests. Although some techniques are better established than others, the guidelines panelists agree that any screening is better than none. Important updates for 2010 include the addition of surveillance guidelines and definitions for several polyposis syndromes, including Peutz-Jeghers syndrome and juvenile polyposis syndrome, and modifications to screening modality and schedule recommendations.

KW - APC

KW - Adenoma

KW - Colon cancer screening

KW - Colon polyp

KW - Colonoscopy

KW - Colorectal cancer

KW - FAP

KW - FIT test

KW - Fecal occult blood test

KW - HNPCC

KW - Lynch syndrome

KW - NCCN clinical practice guidelines

KW - Stool DNA

UR - http://www.scopus.com/inward/record.url?scp=76549120768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76549120768&partnerID=8YFLogxK

M3 - Review article

C2 - 20064289

AN - SCOPUS:76549120768

VL - 8

SP - 8

EP - 60

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -